Need professional-grade analysis? Visit stockanalysis.com
$2.14B
N/A
208
N/A
Ascletis Pharma Inc (ASCLF) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $2.20, up 4.76% from the previous close.
Over the past year, ASCLF has traded between a low of $0.62 and a high of $2.25. The stock has gained 253.9% over this period. It is currently 253.9% above its 52-week low.
Ascletis Pharma Inc has a market capitalization of $2.14B.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.